Growth Metrics

Verastem (VSTM) Receivables - Net (2018 - 2026)

Verastem's quarterly Receivables - Net came in at $10.2 million in Q1 2026, up 15.26% quarter-over-quarter from $8.8 million in Q4 2025.

Verastem has reported Receivables - Net for 9 years, with the latest figure at $10.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Receivables - Net changed N/A year-over-year to $10.2 million; the trailing twelve-month figure through Mar 2026 stood at $10.2 million (changed N/A YoY), and the FY2025 full-year result was $8.8 million, changed N/A from the prior year.
  • Receivables - Net for Q1 2026 stood at $10.2 million, up from $8.8 million in the prior quarter.
  • The five-year high for Receivables - Net was $10.2 million in Q1 2026, with the low at $2000.0 in Q2 2023.
  • Average Receivables - Net over 5 years is $4.1 million, with a median of $2.4 million recorded in 2022.
  • Year-over-year, Receivables - Net slumped 98.47% in 2023 and surged 499900.0% in 2024.
  • Tracing VSTM's Receivables - Net over 5 years: stood at $31000.0 in 2022, then sank by 93.55% to $2000.0 in 2023, then surged by 499900.0% to $10.0 million in 2024, then dropped by 11.87% to $8.8 million in 2025, then increased by 15.26% to $10.2 million in 2026.
  • The last three Receivables - Net figures came in at $10.2 million (Q1 2026), $8.8 million (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Verastem 425.60 Mn 243.93 Mn 15.90 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.16 Mn
Mar 31, 2026 10.16 Mn
Dec 31, 2025 8.81 Mn
Dec 31, 2025 8.81 Mn
Sep 30, 2025 6.72 Mn
Sep 30, 2025 6.72 Mn
Jun 30, 2025 2.08 Mn
Jun 30, 2025 2.08 Mn
Jun 30, 2024 10.00 Mn
Jun 30, 2024 10.00 Mn
Jun 30, 2023 2,000.00
Jun 30, 2023 2,000.00
Dec 31, 2022 31,000.00
Dec 31, 2022 31,000.00
Sep 30, 2022 74,000.00
Sep 30, 2022 74,000.00
Jun 30, 2022 131,000.00
Jun 30, 2022 131,000.00
Mar 31, 2022 2.64 Mn
Mar 31, 2022 2.64 Mn
Dec 31, 2021 516,000.00
Dec 31, 2021 516,000.00
Sep 30, 2021 105,000.00
Sep 30, 2021 105,000.00
Jun 30, 2021 476,000.00
Jun 30, 2021 476,000.00
Mar 31, 2021 1.13 Mn
Mar 31, 2021 1.13 Mn
Dec 31, 2020 239,000.00
Dec 31, 2020 239,000.00
Sep 30, 2020 5.69 Mn
Sep 30, 2020 5.69 Mn
Jun 30, 2020 1.50 Mn
Jun 30, 2020 1.50 Mn
Mar 31, 2020 3.33 Mn
Mar 31, 2020 3.33 Mn
Dec 31, 2019 2.52 Mn
Dec 31, 2019 2.52 Mn
Sep 30, 2019 2.20 Mn
Sep 30, 2019 2.20 Mn
Jun 30, 2019 1.39 Mn
Jun 30, 2019 1.39 Mn
Mar 31, 2019 558,000.00
Mar 31, 2019 558,000.00
Dec 31, 2018 306,000.00
Dec 31, 2018 306,000.00
Sep 30, 2018 10.56 Mn
Sep 30, 2018 10.56 Mn